Nextera Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
5
Nextera General Information
Description
Developer of an antibody discovery platform designed to identify therapeutic antibodies targeting intracellular disease markers. The company offers TCR-like antibody discovery capabilities targeting peptide-human leukocyte antigen complexes and access to intracellular targets through class I and class II presentation, enabling biopharmaceutical companies and therapeutic developers to advance treatments for autoimmune and oncology indications. Developer of an antibody discovery platform designed to identify antibodies targeting peptide-human leukocyte antigen complexes for therapeutic development. The company's platform offers TCR-like antibody discovery capabilities, access to intracellular targets through class I and class II peptide-human leukocyte antigen presentation, and collaborative drug development support, enabling biotechnology and pharmaceutical companies to develop therapies for autoimmune and oncology indications.
Contact Information
Website
www.nextera.noCorporate Office
- Oslo Tech
- Gaustadalléen 21
- 0349 Oslo
- Norway
Corporate Office
- Oslo Tech
- Gaustadalléen 21
- 0349 Oslo
- Norway
Nextera Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Accelerator/Incubator | Completed | Product Development | ||||
| 8. Secondary Transaction - Private | 01-Apr-2021 | Completed | Product Development | |||
| 7. Grant | 01-Feb-2016 | Completed | Product Development | |||
| 6. Early Stage VC | 19-Aug-2012 | Completed | Startup | |||
| 5. Secondary Transaction - Private | 04-Jul-2012 | Completed | Startup | |||
| 4. Early Stage VC | 01-May-2011 | Completed | Startup | |||
| 3. Early Stage VC | 06-Dec-2010 | Completed | Startup | |||
| 2. Early Stage VC | 01-Aug-2009 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2009 | Completed | Startup |
Nextera Comparisons
Industry
Financing
Details
Nextera Competitors (7)
One of Nextera’s 7 competitors is Adaptimmune Therapeutics, a Formerly VC-backed company based in Abingdon, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Fairjourney Biologics | Private Equity-Backed | Porto, Portugal | ||||
| Immunocore Holdings | Formerly VC-backed | Abingdon, United Kingdom | ||||
| .Avidity | Corporation | Aurora, CO | ||||
| Alloy Therapeutics | Venture Capital-Backed | Waltham, MA |
Nextera Patents
Nextera Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202409181-D0 | Antigen binding proteins | Inactive | 26-Jun-2024 | ||
| GB-202409182-D0 | Antigen binding proteins | Inactive | 26-Jun-2024 | ||
| EP-4827929-A1 | Antibody conjugate | Pending | 22-Dec-2023 | ||
| GB-202319932-D0 | Antibody conjugate | Inactive | 22-Dec-2023 | ||
| WO-2025133346-A1 | Antibody conjugate | Inactive | 22-Dec-2023 | A61P37/06 |
Nextera Signals
Nextera Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Research Council of Norway | Government | |||
| Radforsk Investeringsstiftelse | Venture Capital | Minority | ||
| Birk Venture | Venture Capital | Minority | ||
| University of Oslo | University | |||
| ShareLab Incubator | Accelerator/Incubator |
Nextera FAQs
-
When was Nextera founded?
Nextera was founded in 2009.
-
Where is Nextera headquartered?
Nextera is headquartered in Oslo, Norway.
-
What is the size of Nextera?
Nextera has 11 total employees.
-
What industry is Nextera in?
Nextera’s primary industry is Drug Discovery.
-
Is Nextera a private or public company?
Nextera is a Private company.
-
What is Nextera’s current revenue?
The current revenue for Nextera is .
-
Who are Nextera’s investors?
Research Council of Norway, Radforsk Investeringsstiftelse, Birk Venture, University of Oslo, and ShareLab Incubator have invested in Nextera.
-
Who are Nextera’s competitors?
Adaptimmune Therapeutics, Fairjourney Biologics, Immunocore Holdings, .Avidity, and Alloy Therapeutics are some of the 7 competitors of Nextera.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process